Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-10-026143
Filing Date
2010-03-19
Accepted
2010-03-18 21:55:53
Documents
6
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K c97681e10vk.htm 10-K 1448090
2 EXHIBIT 10.9 c97681exv10w9.htm EX-10.9 9518
3 EXHIBIT 23.1 c97681exv23w1.htm EX-23.1 1363
4 EXHIBIT 31.1 c97681exv31w1.htm EX-31.1 8393
5 EXHIBIT 32.1 c97681exv32w1.htm EX-32.1 3948
6 GRAPHIC c97681c9768101.gif GRAPHIC 23154
  Complete submission text file 0000950123-10-026143.txt   1504807
Mailing Address 420 STEVENS AVENUE SUITE 210 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 210 SOLANA BEACH CA 92075 (858) 480-0400
Somaxon Pharmaceuticals, Inc. (Filer) CIK: 0001339455 (see all company filings)

EIN.: 200161599 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51665 | Film No.: 10692865
SIC: 2834 Pharmaceutical Preparations